Clinical trial
Trial of Citalopram for the Prevention of Depression
NCT00317746 · Marina Klein, Other · Completed
Key facts
| NCT number | NCT00317746 |
|---|---|
| Title | Trial of Citalopram for the Prevention of Depression |
| Official title | A Randomized, Placebo Controlled Trial of Citalopram for the Prevention of Depression and Its Consequences in HIV-Hepatitis C Co-infected Individuals Initiating Pegylated Interferon/Ribavirin Therapy |
| Acronym | PICCO |
| Lead sponsor | Marina Klein, Other |
| Collaborators | Ontario HIV Treatment Network Schering-Plough Industry CIHR Canadian HIV Trials Network |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depression, HIV Infections, Hepatitis C |
| Intervention type | Drug |
| Interventions | Citalopram, Placebos |
| Enrollment | 76 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Apr 25, 2006 |
| Last update posted | May 22, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: